Fig. 1.
In-field failure risk for lesions treated with (A) stereotactic body versus conventionally fractionated radiation therapy; and (B) high- and low-dose stereotactic body versus conventionally fractionated radiation therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.